Temporomandibular Disorder
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
City TherapeuticsMA - Cambridge
1 programTrauma Exposure and Childhood Trauma in Temporomandibular Joint DisordersN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
City TherapeuticsTrauma Exposure and Childhood Trauma in Temporomandibular Joint Disorders
Clinical Trials (1)
NCT07292103City TherapeuticsTrauma Exposure and Childhood Trauma in Temporomandibular Joint Disorders
Trauma Exposure and Childhood Trauma in Temporomandibular Joint Disorders
Start: May 2025Est. completion: Oct 2025
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.